Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published November 6, 2013 | Supplemental Material + Accepted Version
Journal Article Open

Nickel/Bis(oxazoline)-Catalyzed Asymmetric Negishi Arylations of Racemic Secondary Benzylic Electrophiles to Generate Enantioenriched 1,1-Diarylalkanes

Abstract

A tertiary stereogenic center that bears two different aryl substituents is found in a variety of bioactive compounds, including medicines such as Zoloft and Detrol. We have developed an efficient method for the synthesis of enantioenriched 1,1-diarylalkanes from readily available racemic benzylic alcohols. Formation of a benzylic mesylate (which is not isolated), followed by treatment with an arylzinc reagent, LiI, and a chiral nickel/bis(oxazoline) catalyst, furnishes the Negishi cross-coupling product in high ee and good yield. A wide array of functional groups (e.g., an aryl iodide, a thiophene, and an N-Boc-indole) are compatible with the mild reaction conditions. This method has been applied to a gram-scale synthesis of a precursor to Zoloft.

Additional Information

© 2013 American Chemical Society. Received: August 18, 2013; Published: October 28, 2013. Support has been provided by the NIH (National Institute of General Medical Sciences: R01-GM62871) and Dr. Reddy's Laboratories (E.R.R.C.). We thank Dr. Scott C. Virgil (Caltech Center for Catalysis and Chemical Synthesis, supported by the Gordon and Betty Moore Foundation) and Dr. Nathan D. Schley for assistance.

Attached Files

Accepted Version - nihms535721.pdf

Supplemental Material - ja408561b_si_001.cif

Supplemental Material - ja408561b_si_002.pdf

Files

nihms535721.pdf
Files (4.4 MB)
Name Size Download all
md5:596253fa1a617d2cfe2f645edee246bd
293.5 kB Preview Download
md5:c8f296a1ac3c46d4a48f82145f4bc8e8
4.1 MB Preview Download
md5:6b190089204d2bec749d99871500f0cc
14.6 kB Download

Additional details

Created:
August 19, 2023
Modified:
October 25, 2023